nimacimab glp-1 news plus semaglutide safe, confers significant weight loss Nimacimab Advances in Obesity Treatment

A separate 2025 meta-analysis, including more than 84,000 GLP-1 users across 34 studies, similarly concluded that those taking the drugs were 3.4 times more likely to experience hair loss compared to those who were not

This means that roughly 2 - 3% of the population in the United States may now be taking one of these drugs

So when in doubt, start with your gut

Grouping was based on blood glucose level (using a minimum of 11.1 mM) and body weight

Suppressing glucagon helps prevent blood sugar from rising too high

Loss ~510% We serve patients in Miami Gardens, Miami Lakes, Hialeah, and nearby communities with physician-supervised Tirzepatide weight loss programs